Shire Strengthens its Regenerative Medicine Business with Pervasis Therapeutics Purchase
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 4 (Table of Contents)
Published: 24 Apr-2012
DOI: 10.3833/pdr.v2012.i4.1730 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Shire is to bolster its burgeoning regenerative medicine division by acquiring substantially all of the assets of Pervasis Therapeutics in a deal that is reportedly worth as much as US$200 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS